{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:37:48Z","timestamp":1787769468074,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jceh.2025.102555","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T11:22:12Z","timestamp":1743333732000},"page":"102555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive Factors and Nomogram (MAP-BNP) for Post Stereotactic Body Radiotherapy Survival in Advanced Hepatocellular Carcinoma Patients"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-3384","authenticated-orcid":false,"given":"Deepti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7019-1020","authenticated-orcid":false,"given":"Babu Lal","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanuman Prasad","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju K.","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Jagya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.102555_bib1","first-page":"S0168","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"19","author":"Marina","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.102555_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.102555_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12809\/hkjr2117253","article-title":"Long-term results of palliative stereotactic radiotherapy of barcelona clinic liver cancer stage C hepatitis B\u2013related hepatocellular carcinoma","volume":"24","author":"Choi","year":"2021","journal-title":"Hong Kong J Radiol"},{"key":"10.1016\/j.jceh.2025.102555_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124434","article-title":"Different survival of barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread","volume":"10","author":"Sinn","year":"2015","journal-title":"PLoS One"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2025.102555_bib5","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.21037\/cdt.2017.09.16","article-title":"Tumour thrombus: incidence, imaging, prognosis and treatment","volume":"7","author":"Quencer","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jceh.2025.102555_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5009\/gnl230057","article-title":"Reappraisal of portal vein tumour thrombosis as a prognostic factor for patients with hepatocellular carcinoma","volume":"18","author":"Chang","year":"2024","journal-title":"Gut and Liver"},{"key":"10.1016\/j.jceh.2025.102555_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124434","article-title":"Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread","volume":"10","author":"Sinn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.102555_bib8","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jceh.2025.102555_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102555_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.755920","article-title":"Nomograms incorporating the CNLC staging system predict the outcome of hepatocellular carcinoma after curative resection","volume":"11","author":"Liao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102555_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00066-023-02065-x","article-title":"Role of palliative SBRT in barcelona clinic liver cancer-stage C hepatocellular carcinoma patients","volume":"199","author":"Sharma","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jceh.2025.102555_bib12","series-title":"Radiation Therapy Oncology Group (RTOG) 1112 Randomized Phase Iii Study of Sorafenib versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma","author":"Dawson","year":"2012"},{"key":"10.1016\/j.jceh.2025.102555_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2025.102555_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-023-02292-7","article-title":"Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study","volume":"18","author":"Long","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jceh.2025.102555_bib16","first-page":"341","article-title":"New staging model for radiation-based hepatocellular carcinoma treatment: a national multicenter study","volume":"11","author":"Su","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2025.102555_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1748-717X-8-15","article-title":"Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumour thrombosis","volume":"8","author":"Kim","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jceh.2025.102555_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257556","article-title":"Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: feasibility and clinical outcomes","volume":"16","author":"Khorprasert","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.102555_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-018-1136-5","article-title":"Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumour thrombosis","volume":"13","author":"Shui","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jceh.2025.102555_bib20","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20181053","article-title":"Stereotactic body radio therapy for inoperable large hepatocellular cancers: results from a clinical audit","volume":"92","author":"Chopra","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jceh.2025.102555_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3857\/roj.2021.00934","article-title":"PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy","volume":"40","author":"Cho","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jceh.2025.102555_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4236\/ojgas.2013.31008","article-title":"Alpha-fetoprotein testing for hepatocellular carcinoma may not be helpful in nonalcoholic steatohepatitis","volume":"3","author":"Wong","year":"2013","journal-title":"Open J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102555_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1186\/s12885-021-08469-1","article-title":"Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jceh.2025.102555_bib24","article-title":"Update of Indian national association for study of the liver consensus on management of intermediate and advanced hepatocellular carcinoma: the puri III recommendations","volume":"14","author":"Kumar","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102555_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12885-024-12049-4","article-title":"Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumour Burden Score","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jceh.2025.102555_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000505693","article-title":"Development and validation of a nomogram for patients with nonmetastatic BCLC stage C hepatocellular carcinoma after stereotactic body radiotherapy","volume":"9","author":"Huang","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2025.102555_bib27","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/diagnostics13081442","article-title":"Diagnostic and prognostic nomograms for hepatocellular carcinoma based on PIVKA-II and serum biomarkers","volume":"13","author":"An","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jceh.2025.102555_bib28","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.7314\/APJCP.2014.15.16.6673","article-title":"Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.jceh.2025.102555_bib29","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3748\/wjg.v21.i13.3928","article-title":"Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma","volume":"21","author":"Seo","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:48:13Z","timestamp":1757771293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0973688325000556"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102555","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Factors and Nomogram (MAP-BNP) for Post Stereotactic Body Radiotherapy Survival in Advanced Hepatocellular Carcinoma Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102555"}}